波士顿科学节拍收入估算 并提升了2025年的预测 尽管内幕销售。 Boston Scientific beat earnings estimates and raised its 2025 forecast despite insider selling.

波士顿科学社报告第二季度成绩强劲,每股收入0.75美元,高于估计数0.03美元,收入增长22.8%,达到50.6亿美元。 Boston Scientific reported strong second-quarter results, earning $0.75 per share—$0.03 above estimates—with revenue rising 22.8% to $5.06 billion. 该公司将2025年全年收入预测提高到每股2.85美元,预计Q3收入为0.700-0.720美元。 The company raised its 2025 full-year earnings forecast to $2.85 per share and expects Q3 earnings of $0.700–$0.720. 尽管机构和内部出售的股份共计174 214股,价值1 840万美元,但股票价值仍为98.20美元,市场上限为1455.1亿美元。 Despite institutional and insider selling totaling 174,214 shares worth $18.4 million, the stock remains valued at $98.20 with a market cap of $145.51 billion. 分析员维持“Buy”评级,目标为118.17美元。 Analysts maintain a “Buy” rating with a $118.17 target.